Portage Biotech Inc Financial Flexibility Index
Portage Biotech Inc financial flexibility index. Portage Biotech Inc (PRTG) has a Financial Flexibility Index of -0.78x as of September 2024. Free cash flow of $-1.56 Million (operating CF $-1.56 Million minus capex $0.00) represents -1% of total liabilities ($2.01 Million). See Portage Biotech Inc (PRTG) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Portage Biotech Inc (1998–2025)
Financial flexibility index of Portage Biotech Inc from 1998 to 2025. Historical Financial Flexibility Index trend for Portage Biotech Inc across 27 annual periods. Check Portage Biotech Inc (PRTG) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Portage Biotech Inc Financial Flexibility Index by Year (1998–2025)
Portage Biotech Inc financial flexibility index by year from 1998 to 2025. Year-by-year free cash flow to debt coverage for Portage Biotech Inc. For the full cash flow conversion analysis, see PRTG cash generation efficiency.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.79x | $-5.46 Million | $-5.46 Million | $3.05 Million | ▲ +44.3% |
| 2024 | -3.21x | $-14.30 Million | $-14.30 Million | $4.45 Million | ▼ -531.8% |
| 2023 | -0.51x | $-12.07 Million | $-12.07 Million | $23.73 Million | ▼ -119.8% |
| 2022 | -0.23x | $-6.76 Million | $-6.76 Million | $29.23 Million | ▼ -92.1% |
| 2021 | -0.12x | $-3.28 Million | $-4.28 Million | $27.26 Million | ▲ +10.6% |
| 2020 | -0.13x | $-3.71 Million | $-3.71 Million | $27.53 Million | ▼ -295.2% |
| 2019 | -0.03x | $-858.00K | $-858.00K | $25.16 Million | ▲ +98.8% |
| 2018 | -2.79x | $-1.07 Million | $-1.07 Million | $384.00K | ▲ +34.6% |
| 2017 | -4.27x | $-1.32 Million | $-1.32 Million | $309.43K | ▲ +73.6% |
| 2016 | -16.14x | $-4.84 Million | $-5.84 Million | $299.74K | ▼ -283.3% |
| 2015 | -4.21x | $-2.61 Million | $-2.61 Million | $620.56K | ▲ +58.2% |
| 2014 | -10.08x | $-1.94 Million | $-1.94 Million | $191.97K | ▼ -151.6% |
| 2013 | -4.01x | $-1.79 Million | $-1.79 Million | $446.87K | ▼ -696.0% |
| 2012 | -0.50x | $-1.34 Million | $-1.34 Million | $2.66 Million | ▲ +85.1% |
| 2011 | -3.38x | $-2.30 Million | $-2.62 Million | $682.75K | ▼ -374.3% |
| 2010 | 1.23x | $4.25 Million | $-356.14K | $3.45 Million | ▲ +152.3% |
| 2009 | -2.35x | $-283.22K | $-287.38K | $120.39K | ▲ +70.8% |
| 2008 | -8.06x | $-462.10K | $-468.92K | $57.34K | ▲ +25.7% |
| 2007 | -10.84x | $-455.25K | $-458.84K | $42.00K | ▼ -161.5% |
| 2006 | 17.63x | $2.50 Million | $-645.50K | $141.52K | ▲ +3723.5% |
| 2004 | -0.49x | $-321.51K | $-321.51K | $660.63K | ▲ +22.5% |
| 2003 | -0.63x | $-146.90K | $-146.90K | $233.80K | ▲ +49.2% |
| 2002 | -1.24x | $-156.58K | $-156.80K | $126.48K | ▲ +65.1% |
| 2001 | -3.55x | $-335.67K | $-347.00K | $94.62K | ▼ -52.5% |
| 2000 | -2.33x | $-352.74K | $-466.90K | $151.67K | ▲ +54.3% |
| 1999 | -5.09x | $-331.22K | $-345.09K | $65.14K | ▼ -498.3% |
| 1998 | -0.85x | $-422.15K | $-422.97K | $496.67K | — |